Brush Up on Biosimilars
January 2025
You’ll see more biosimilar use...now that there are over 60 available in the US. And over 16 were approved in 2024 alone.
For example, there are now several biosimilars approved for ustekinumab (Stelara)...with ustekinumab-kfce (Yesintek) being the latest.
Keep in mind, biosimilars aren’t generics. It’s not possible to create an exact copy of the original reference product...since biologics contain larger, more complex molecules than most traditional drugs.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote